Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (Frankfurt: L0MA) (“Nextleaf”, “OILS” or the “Company”), an extraction technology company that owns a portfolio of issued and pending patents pertaining to the Company’s industrial-scale process of extraction and purification of cannabinoids, is pleased to announce the completion of two research and development projects with the National Research Council of Canada’sIndustrial Research Assistance Program (“IRAP”), and the Natural Science and Engineering Council (“NSERC”).

During the yearlong IRAP project, Nextleaf successfully developed a media treatment process to remove undesirable elements such as chlorophyll, carotenoids, and anthocyanins from crude extract. The project was conducted using common hops (Humulus lupulus), a suitable analog for cannabis as the two are genetically related, and contain a similar pigment and oil profile.


The five-person research team – including four PhDs – was led by Nextleaf’s Engineering Manager, Krupal Pal, PhD, P.Eng. “We found unique ways to adapt existing validated technology from complimentary industries such as oenology, as well as drawing on my previous experience in oil and gas refinement” stated Dr. Pal.

Technology developed during the IRAP funded R&D project will be applied within Nextleaf’s patented extraction process and used in the production of THC and CBD distillates for vapes, edibles, and beverages once legalized in Canada. “Chlorophyll and other pigments can affect the consumer experience in a number of ways, including inferior taste and appearance,” said Dr. Krupal Pal, “but more importantly chlorophyll can affect the functionality of vape hardware as it has a different temperature tolerance and vaporizes at a different rate compared to THC and CBD.”

Additionally, Dr. Pal led efforts with regards to Nextleaf’s collaborative research project with the University of British Columbia (UBC), and British Columbia Institute of Technology (BCIT) under the auspices of an NSERC grant. The project was anchored in a sustainability-driven outcome with the goal to repurpose post-extraction cannabis biomass, and minimize waste biproducts.

Hemp biomass, when reduced to ash under Nextleaf’s incineration process, shows considerable promise as a replacement for fly ash as a key ingredient in Portland Cement due to the silica content. When leveraged as a biofuel during hemp ash production, power is generated and metric tonnes of biomass can be diverted from landfills and used as a supplementary cementitious material. Current estimates indicate close to a billion kilograms of biomass being harvested annually by the marijuana and hemp industry.

“We were adamant on finding an environmentally conscious way to put cannabis biomass waste used in our extraction process to good use, and the evidence suggests we’ve found it,” stated Paul Pedersen, CEO of Nextleaf Solutions. “These two R&D projects speak to Nextleaf’s talent for research collaboration and technological innovation, key pillars in our growth strategy.”

As a direct result of the two government funded R&D projects, OILS has filed additional U.S. patent applications increasing its IP portfolio.

About Nextleaf Solutions
Nextleaf Solutions Ltd. (“OILS”) is the first publicly traded company to be issued a U.S. patent for industrial-scale extraction and purification of cannabinoids. OILS owns a portfolio of 3 issued and 24 pending patents pertaining to the production of high-purity cannabinoid distillate, the precursor used in the manufacturing of standardized THC and CBD based products. Once cannabis concentrates become legal across Canada on October 17, 2019, the company plans to commercialize its intellectual property portfolio through IP licensing, B2B processing services, and the supply of oils and concentrates to qualified Canadian and international partners.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange (CSE: OILS), OILFF on the OTCQB Market in the United States (OTCQB: OILFF) and L0MA on the Frankfurt Stock Exchange (FRA: L0MA).

Follow OILS on Twitter, LinkedIn, Facebook, Instagram and YouTube.
www.NextleafSolutions.com

Contact:
Adel Fares, Investor Relations
604-283-2301 (ext. 201)
investors@nextleafsolutions.com

Paul Pedersen, CEO
paul@nextleafsolutions.com

CAUTIONARY STATEMENT:
The securities described herein, if any, have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and may not be offered or sold within the United States or to, or for the benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act) except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any of Nextleaf securities in the United States. This news release may contain “forward-looking information” as defined in applicable Canadian securities legislation. All statements other than statements of historical fact included in this release, including, without limitation, future operating margins, future production and processing, processing results, and future plans and objectives of Nextleaf, constitute forward looking information that involve various risks and uncertainties. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect, including, but not limited to, assumptions in connection with the continuance of Nextleaf and its subsidiaries as a going concern, general economic and market conditions, price of biomass, the accuracy of production resource estimates, and the performance of Nextleaf future operations. There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information. Important factors that could cause actual results to differ materially from Nextleaf’s expectations include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. For additional information with respect to risk factors, reference Nextleaf’s continuous disclosure materials filed from time to time with securities regulators, including, but not limited to, Nextleaf’s CSE Listing Statement. The forward-looking information contained in this release is made as of the date of this release. Nextleaf does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The CSE has not reviewed, approved or disapproved the contents of this press release.

 

Click here to connect with Nextleaf Solutions Ltd. (CSE:OILS, OTCQB:OILFF, Frankfurt:L0MA) for an Investor Presentation.

Source: www.newswire.ca

US-based multi-state operators (MSOs) performed well during Q1, but one fund manager believes that hasn’t been reflected in their share prices.

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) announced today that its proprietary and patented combinatorial mushroom preparations AION F7 and AION F8 (collectively, the ” Aion Mushroom Preparations ” or ” Preparations “) showed high efficacy in killing HER2+ breast cancer cells, ER+PR+ breast cancer cells, and triple-negative breast cancer cells by direct cytotoxicity.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”) , the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary Nextleaf Labs Ltd. (“Nextleaf Labs” or “Labs”) has completed an inaugural bulk CBD distillate delivery to a U.S.-listed, Canadian-based global cannabis company. The Company anticipates similar orders on an ongoing basis.

Keep reading... Show less

The Company Will Tap into Southern Glazer’s Established Distribution Network to Bring Quatreau, its CBD-Infused Sparkling Water, to U.S. Retailers

 Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, CBD and vaporization device company, today announced Southern Glazer’s Wine & Spirits (“Southern Glazer’s”), the world’s pre-eminent distributor of beverage alcohol, as the distribution partner for its U.S. portfolio of CBD-infused beverages. This partnership announcement follows the recent launch of Quatreau Canopy’s first line of CBD-infused beverages sold in the U.S market.

Keep reading... Show less

 Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) announces its subsidiary Empathy Plant Co. has completed the full development of its vegan multivitamin formula exclusively for women.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7448/81051_95aa98db045cb95d_001.jpg
Unique Vegan Women’s Multi-Vitamin with 100% Compostable Packaging

Keep reading... Show less